Human Vaccines Administered Orally Market - Global Outlook and Forecast 2022-2028
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
This report contains market size and forecasts of Human Vaccines Administered Orally in global, including the following market information:
Global Human Vaccines Administered Orally Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Human Vaccines Administered Orally Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Human Vaccines Administered Orally companies in 2021 (%)
The global Human Vaccines Administered Orally market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Rotavirus Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Vaccines Administered Orally include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Vaccines Administered Orally manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Vaccines Administered Orally Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Vaccines Administered Orally Market Segment Percentages, by Type, 2021 (%)
Global Human Vaccines Administered Orally Market Segment Percentages, by Application, 2021 (%)
Global Human Vaccines Administered Orally Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Human Vaccines Administered Orally revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Human Vaccines Administered Orally revenues share in global market, 2021 (%)
Key companies Human Vaccines Administered Orally sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Human Vaccines Administered Orally sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Human Vaccines Administered Orally in global, including the following market information:
Global Human Vaccines Administered Orally Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Human Vaccines Administered Orally Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Human Vaccines Administered Orally companies in 2021 (%)
The global Human Vaccines Administered Orally market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Rotavirus Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Vaccines Administered Orally include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Vaccines Administered Orally manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Vaccines Administered Orally Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Vaccines Administered Orally Market Segment Percentages, by Type, 2021 (%)
- Rotavirus Vaccine
- Cholera Vaccine
- Oral Polio Vaccine
Global Human Vaccines Administered Orally Market Segment Percentages, by Application, 2021 (%)
- Public
- Private
Global Human Vaccines Administered Orally Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Human Vaccines Administered Orally revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Human Vaccines Administered Orally revenues share in global market, 2021 (%)
Key companies Human Vaccines Administered Orally sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Human Vaccines Administered Orally sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Merck
- GSK
- Sanofi
- Lanzhou Institute
- Serum Institute
- Valneva
- Shanghai United Cell
- Bibcol
- PaxVax
- Vabiotech
- Tiantan Biological
- EuBiologics
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Human Vaccines Administered Orally Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Vaccines Administered Orally Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL HUMAN VACCINES ADMINISTERED ORALLY OVERALL MARKET SIZE
2.1 Global Human Vaccines Administered Orally Market Size: 2021 VS 2028
2.2 Global Human Vaccines Administered Orally Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Human Vaccines Administered Orally Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Human Vaccines Administered Orally Players in Global Market
3.2 Top Global Human Vaccines Administered Orally Companies Ranked by Revenue
3.3 Global Human Vaccines Administered Orally Revenue by Companies
3.4 Global Human Vaccines Administered Orally Sales by Companies
3.5 Global Human Vaccines Administered Orally Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Human Vaccines Administered Orally Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Human Vaccines Administered Orally Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Vaccines Administered Orally Players in Global Market
3.8.1 List of Global Tier 1 Human Vaccines Administered Orally Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Vaccines Administered Orally Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Human Vaccines Administered Orally Market Size Markets, 2021 & 2028
4.1.2 Rotavirus Vaccine
4.1.3 Cholera Vaccine
4.1.4 Oral Polio Vaccine
4.2 By Type - Global Human Vaccines Administered Orally Revenue & Forecasts
4.2.1 By Type - Global Human Vaccines Administered Orally Revenue, 2017-2022
4.2.2 By Type - Global Human Vaccines Administered Orally Revenue, 2023-2028
4.2.3 By Type - Global Human Vaccines Administered Orally Revenue Market Share, 2017-2028
4.3 By Type - Global Human Vaccines Administered Orally Sales & Forecasts
4.3.1 By Type - Global Human Vaccines Administered Orally Sales, 2017-2022
4.3.2 By Type - Global Human Vaccines Administered Orally Sales, 2023-2028
4.3.3 By Type - Global Human Vaccines Administered Orally Sales Market Share, 2017-2028
4.4 By Type - Global Human Vaccines Administered Orally Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Human Vaccines Administered Orally Market Size, 2021 & 2028
5.1.2 Public
5.1.3 Private
5.2 By Application - Global Human Vaccines Administered Orally Revenue & Forecasts
5.2.1 By Application - Global Human Vaccines Administered Orally Revenue, 2017-2022
5.2.2 By Application - Global Human Vaccines Administered Orally Revenue, 2023-2028
5.2.3 By Application - Global Human Vaccines Administered Orally Revenue Market Share, 2017-2028
5.3 By Application - Global Human Vaccines Administered Orally Sales & Forecasts
5.3.1 By Application - Global Human Vaccines Administered Orally Sales, 2017-2022
5.3.2 By Application - Global Human Vaccines Administered Orally Sales, 2023-2028
5.3.3 By Application - Global Human Vaccines Administered Orally Sales Market Share, 2017-2028
5.4 By Application - Global Human Vaccines Administered Orally Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Human Vaccines Administered Orally Market Size, 2021 & 2028
6.2 By Region - Global Human Vaccines Administered Orally Revenue & Forecasts
6.2.1 By Region - Global Human Vaccines Administered Orally Revenue, 2017-2022
6.2.2 By Region - Global Human Vaccines Administered Orally Revenue, 2023-2028
6.2.3 By Region - Global Human Vaccines Administered Orally Revenue Market Share, 2017-2028
6.3 By Region - Global Human Vaccines Administered Orally Sales & Forecasts
6.3.1 By Region - Global Human Vaccines Administered Orally Sales, 2017-2022
6.3.2 By Region - Global Human Vaccines Administered Orally Sales, 2023-2028
6.3.3 By Region - Global Human Vaccines Administered Orally Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Human Vaccines Administered Orally Revenue, 2017-2028
6.4.2 By Country - North America Human Vaccines Administered Orally Sales, 2017-2028
6.4.3 US Human Vaccines Administered Orally Market Size, 2017-2028
6.4.4 Canada Human Vaccines Administered Orally Market Size, 2017-2028
6.4.5 Mexico Human Vaccines Administered Orally Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Human Vaccines Administered Orally Revenue, 2017-2028
6.5.2 By Country - Europe Human Vaccines Administered Orally Sales, 2017-2028
6.5.3 Germany Human Vaccines Administered Orally Market Size, 2017-2028
6.5.4 France Human Vaccines Administered Orally Market Size, 2017-2028
6.5.5 U.K. Human Vaccines Administered Orally Market Size, 2017-2028
6.5.6 Italy Human Vaccines Administered Orally Market Size, 2017-2028
6.5.7 Russia Human Vaccines Administered Orally Market Size, 2017-2028
6.5.8 Nordic Countries Human Vaccines Administered Orally Market Size, 2017-2028
6.5.9 Benelux Human Vaccines Administered Orally Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Human Vaccines Administered Orally Revenue, 2017-2028
6.6.2 By Region - Asia Human Vaccines Administered Orally Sales, 2017-2028
6.6.3 China Human Vaccines Administered Orally Market Size, 2017-2028
6.6.4 Japan Human Vaccines Administered Orally Market Size, 2017-2028
6.6.5 South Korea Human Vaccines Administered Orally Market Size, 2017-2028
6.6.6 Southeast Asia Human Vaccines Administered Orally Market Size, 2017-2028
6.6.7 India Human Vaccines Administered Orally Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Human Vaccines Administered Orally Revenue, 2017-2028
6.7.2 By Country - South America Human Vaccines Administered Orally Sales, 2017-2028
6.7.3 Brazil Human Vaccines Administered Orally Market Size, 2017-2028
6.7.4 Argentina Human Vaccines Administered Orally Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Vaccines Administered Orally Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Human Vaccines Administered Orally Sales, 2017-2028
6.8.3 Turkey Human Vaccines Administered Orally Market Size, 2017-2028
6.8.4 Israel Human Vaccines Administered Orally Market Size, 2017-2028
6.8.5 Saudi Arabia Human Vaccines Administered Orally Market Size, 2017-2028
6.8.6 UAE Human Vaccines Administered Orally Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Human Vaccines Administered Orally Major Product Offerings
7.1.4 Merck Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.1.5 Merck Key News
7.2 GSK
7.2.1 GSK Corporate Summary
7.2.2 GSK Business Overview
7.2.3 GSK Human Vaccines Administered Orally Major Product Offerings
7.2.4 GSK Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.2.5 GSK Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Human Vaccines Administered Orally Major Product Offerings
7.3.4 Sanofi Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.3.5 Sanofi Key News
7.4 Lanzhou Institute
7.4.1 Lanzhou Institute Corporate Summary
7.4.2 Lanzhou Institute Business Overview
7.4.3 Lanzhou Institute Human Vaccines Administered Orally Major Product Offerings
7.4.4 Lanzhou Institute Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.4.5 Lanzhou Institute Key News
7.5 Serum Institute
7.5.1 Serum Institute Corporate Summary
7.5.2 Serum Institute Business Overview
7.5.3 Serum Institute Human Vaccines Administered Orally Major Product Offerings
7.5.4 Serum Institute Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.5.5 Serum Institute Key News
7.6 Valneva
7.6.1 Valneva Corporate Summary
7.6.2 Valneva Business Overview
7.6.3 Valneva Human Vaccines Administered Orally Major Product Offerings
7.6.4 Valneva Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.6.5 Valneva Key News
7.7 Shanghai United Cell
7.7.1 Shanghai United Cell Corporate Summary
7.7.2 Shanghai United Cell Business Overview
7.7.3 Shanghai United Cell Human Vaccines Administered Orally Major Product Offerings
7.7.4 Shanghai United Cell Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.7.5 Shanghai United Cell Key News
7.8 Bibcol
7.8.1 Bibcol Corporate Summary
7.8.2 Bibcol Business Overview
7.8.3 Bibcol Human Vaccines Administered Orally Major Product Offerings
7.8.4 Bibcol Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.8.5 Bibcol Key News
7.9 PaxVax
7.9.1 PaxVax Corporate Summary
7.9.2 PaxVax Business Overview
7.9.3 PaxVax Human Vaccines Administered Orally Major Product Offerings
7.9.4 PaxVax Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.9.5 PaxVax Key News
7.10 Vabiotech
7.10.1 Vabiotech Corporate Summary
7.10.2 Vabiotech Business Overview
7.10.3 Vabiotech Human Vaccines Administered Orally Major Product Offerings
7.10.4 Vabiotech Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.10.5 Vabiotech Key News
7.11 Tiantan Biological
7.11.1 Tiantan Biological Corporate Summary
7.11.2 Tiantan Biological Human Vaccines Administered Orally Business Overview
7.11.3 Tiantan Biological Human Vaccines Administered Orally Major Product Offerings
7.11.4 Tiantan Biological Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.11.5 Tiantan Biological Key News
7.12 EuBiologics
7.12.1 EuBiologics Corporate Summary
7.12.2 EuBiologics Human Vaccines Administered Orally Business Overview
7.12.3 EuBiologics Human Vaccines Administered Orally Major Product Offerings
7.12.4 EuBiologics Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.12.5 EuBiologics Key News
7.13 Panacea Biotec Ltd
7.13.1 Panacea Biotec Ltd Corporate Summary
7.13.2 Panacea Biotec Ltd Human Vaccines Administered Orally Business Overview
7.13.3 Panacea Biotec Ltd Human Vaccines Administered Orally Major Product Offerings
7.13.4 Panacea Biotec Ltd Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.13.5 Panacea Biotec Ltd Key News
7.14 Bio-Med
7.14.1 Bio-Med Corporate Summary
7.14.2 Bio-Med Business Overview
7.14.3 Bio-Med Human Vaccines Administered Orally Major Product Offerings
7.14.4 Bio-Med Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.14.5 Bio-Med Key News
7.15 Halfkin Bio-Pharmaceuticals
7.15.1 Halfkin Bio-Pharmaceuticals Corporate Summary
7.15.2 Halfkin Bio-Pharmaceuticals Business Overview
7.15.3 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Major Product Offerings
7.15.4 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.15.5 Halfkin Bio-Pharmaceuticals Key News
8 GLOBAL HUMAN VACCINES ADMINISTERED ORALLY PRODUCTION CAPACITY, ANALYSIS
8.1 Global Human Vaccines Administered Orally Production Capacity, 2017-2028
8.2 Human Vaccines Administered Orally Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Vaccines Administered Orally Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 HUMAN VACCINES ADMINISTERED ORALLY SUPPLY CHAIN ANALYSIS
10.1 Human Vaccines Administered Orally Industry Value Chain
10.2 Human Vaccines Administered Orally Upstream Market
10.3 Human Vaccines Administered Orally Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Vaccines Administered Orally Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Human Vaccines Administered Orally Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Vaccines Administered Orally Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL HUMAN VACCINES ADMINISTERED ORALLY OVERALL MARKET SIZE
2.1 Global Human Vaccines Administered Orally Market Size: 2021 VS 2028
2.2 Global Human Vaccines Administered Orally Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Human Vaccines Administered Orally Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Human Vaccines Administered Orally Players in Global Market
3.2 Top Global Human Vaccines Administered Orally Companies Ranked by Revenue
3.3 Global Human Vaccines Administered Orally Revenue by Companies
3.4 Global Human Vaccines Administered Orally Sales by Companies
3.5 Global Human Vaccines Administered Orally Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Human Vaccines Administered Orally Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Human Vaccines Administered Orally Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Vaccines Administered Orally Players in Global Market
3.8.1 List of Global Tier 1 Human Vaccines Administered Orally Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Vaccines Administered Orally Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Human Vaccines Administered Orally Market Size Markets, 2021 & 2028
4.1.2 Rotavirus Vaccine
4.1.3 Cholera Vaccine
4.1.4 Oral Polio Vaccine
4.2 By Type - Global Human Vaccines Administered Orally Revenue & Forecasts
4.2.1 By Type - Global Human Vaccines Administered Orally Revenue, 2017-2022
4.2.2 By Type - Global Human Vaccines Administered Orally Revenue, 2023-2028
4.2.3 By Type - Global Human Vaccines Administered Orally Revenue Market Share, 2017-2028
4.3 By Type - Global Human Vaccines Administered Orally Sales & Forecasts
4.3.1 By Type - Global Human Vaccines Administered Orally Sales, 2017-2022
4.3.2 By Type - Global Human Vaccines Administered Orally Sales, 2023-2028
4.3.3 By Type - Global Human Vaccines Administered Orally Sales Market Share, 2017-2028
4.4 By Type - Global Human Vaccines Administered Orally Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Human Vaccines Administered Orally Market Size, 2021 & 2028
5.1.2 Public
5.1.3 Private
5.2 By Application - Global Human Vaccines Administered Orally Revenue & Forecasts
5.2.1 By Application - Global Human Vaccines Administered Orally Revenue, 2017-2022
5.2.2 By Application - Global Human Vaccines Administered Orally Revenue, 2023-2028
5.2.3 By Application - Global Human Vaccines Administered Orally Revenue Market Share, 2017-2028
5.3 By Application - Global Human Vaccines Administered Orally Sales & Forecasts
5.3.1 By Application - Global Human Vaccines Administered Orally Sales, 2017-2022
5.3.2 By Application - Global Human Vaccines Administered Orally Sales, 2023-2028
5.3.3 By Application - Global Human Vaccines Administered Orally Sales Market Share, 2017-2028
5.4 By Application - Global Human Vaccines Administered Orally Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Human Vaccines Administered Orally Market Size, 2021 & 2028
6.2 By Region - Global Human Vaccines Administered Orally Revenue & Forecasts
6.2.1 By Region - Global Human Vaccines Administered Orally Revenue, 2017-2022
6.2.2 By Region - Global Human Vaccines Administered Orally Revenue, 2023-2028
6.2.3 By Region - Global Human Vaccines Administered Orally Revenue Market Share, 2017-2028
6.3 By Region - Global Human Vaccines Administered Orally Sales & Forecasts
6.3.1 By Region - Global Human Vaccines Administered Orally Sales, 2017-2022
6.3.2 By Region - Global Human Vaccines Administered Orally Sales, 2023-2028
6.3.3 By Region - Global Human Vaccines Administered Orally Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Human Vaccines Administered Orally Revenue, 2017-2028
6.4.2 By Country - North America Human Vaccines Administered Orally Sales, 2017-2028
6.4.3 US Human Vaccines Administered Orally Market Size, 2017-2028
6.4.4 Canada Human Vaccines Administered Orally Market Size, 2017-2028
6.4.5 Mexico Human Vaccines Administered Orally Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Human Vaccines Administered Orally Revenue, 2017-2028
6.5.2 By Country - Europe Human Vaccines Administered Orally Sales, 2017-2028
6.5.3 Germany Human Vaccines Administered Orally Market Size, 2017-2028
6.5.4 France Human Vaccines Administered Orally Market Size, 2017-2028
6.5.5 U.K. Human Vaccines Administered Orally Market Size, 2017-2028
6.5.6 Italy Human Vaccines Administered Orally Market Size, 2017-2028
6.5.7 Russia Human Vaccines Administered Orally Market Size, 2017-2028
6.5.8 Nordic Countries Human Vaccines Administered Orally Market Size, 2017-2028
6.5.9 Benelux Human Vaccines Administered Orally Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Human Vaccines Administered Orally Revenue, 2017-2028
6.6.2 By Region - Asia Human Vaccines Administered Orally Sales, 2017-2028
6.6.3 China Human Vaccines Administered Orally Market Size, 2017-2028
6.6.4 Japan Human Vaccines Administered Orally Market Size, 2017-2028
6.6.5 South Korea Human Vaccines Administered Orally Market Size, 2017-2028
6.6.6 Southeast Asia Human Vaccines Administered Orally Market Size, 2017-2028
6.6.7 India Human Vaccines Administered Orally Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Human Vaccines Administered Orally Revenue, 2017-2028
6.7.2 By Country - South America Human Vaccines Administered Orally Sales, 2017-2028
6.7.3 Brazil Human Vaccines Administered Orally Market Size, 2017-2028
6.7.4 Argentina Human Vaccines Administered Orally Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Vaccines Administered Orally Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Human Vaccines Administered Orally Sales, 2017-2028
6.8.3 Turkey Human Vaccines Administered Orally Market Size, 2017-2028
6.8.4 Israel Human Vaccines Administered Orally Market Size, 2017-2028
6.8.5 Saudi Arabia Human Vaccines Administered Orally Market Size, 2017-2028
6.8.6 UAE Human Vaccines Administered Orally Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Human Vaccines Administered Orally Major Product Offerings
7.1.4 Merck Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.1.5 Merck Key News
7.2 GSK
7.2.1 GSK Corporate Summary
7.2.2 GSK Business Overview
7.2.3 GSK Human Vaccines Administered Orally Major Product Offerings
7.2.4 GSK Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.2.5 GSK Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Human Vaccines Administered Orally Major Product Offerings
7.3.4 Sanofi Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.3.5 Sanofi Key News
7.4 Lanzhou Institute
7.4.1 Lanzhou Institute Corporate Summary
7.4.2 Lanzhou Institute Business Overview
7.4.3 Lanzhou Institute Human Vaccines Administered Orally Major Product Offerings
7.4.4 Lanzhou Institute Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.4.5 Lanzhou Institute Key News
7.5 Serum Institute
7.5.1 Serum Institute Corporate Summary
7.5.2 Serum Institute Business Overview
7.5.3 Serum Institute Human Vaccines Administered Orally Major Product Offerings
7.5.4 Serum Institute Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.5.5 Serum Institute Key News
7.6 Valneva
7.6.1 Valneva Corporate Summary
7.6.2 Valneva Business Overview
7.6.3 Valneva Human Vaccines Administered Orally Major Product Offerings
7.6.4 Valneva Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.6.5 Valneva Key News
7.7 Shanghai United Cell
7.7.1 Shanghai United Cell Corporate Summary
7.7.2 Shanghai United Cell Business Overview
7.7.3 Shanghai United Cell Human Vaccines Administered Orally Major Product Offerings
7.7.4 Shanghai United Cell Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.7.5 Shanghai United Cell Key News
7.8 Bibcol
7.8.1 Bibcol Corporate Summary
7.8.2 Bibcol Business Overview
7.8.3 Bibcol Human Vaccines Administered Orally Major Product Offerings
7.8.4 Bibcol Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.8.5 Bibcol Key News
7.9 PaxVax
7.9.1 PaxVax Corporate Summary
7.9.2 PaxVax Business Overview
7.9.3 PaxVax Human Vaccines Administered Orally Major Product Offerings
7.9.4 PaxVax Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.9.5 PaxVax Key News
7.10 Vabiotech
7.10.1 Vabiotech Corporate Summary
7.10.2 Vabiotech Business Overview
7.10.3 Vabiotech Human Vaccines Administered Orally Major Product Offerings
7.10.4 Vabiotech Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.10.5 Vabiotech Key News
7.11 Tiantan Biological
7.11.1 Tiantan Biological Corporate Summary
7.11.2 Tiantan Biological Human Vaccines Administered Orally Business Overview
7.11.3 Tiantan Biological Human Vaccines Administered Orally Major Product Offerings
7.11.4 Tiantan Biological Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.11.5 Tiantan Biological Key News
7.12 EuBiologics
7.12.1 EuBiologics Corporate Summary
7.12.2 EuBiologics Human Vaccines Administered Orally Business Overview
7.12.3 EuBiologics Human Vaccines Administered Orally Major Product Offerings
7.12.4 EuBiologics Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.12.5 EuBiologics Key News
7.13 Panacea Biotec Ltd
7.13.1 Panacea Biotec Ltd Corporate Summary
7.13.2 Panacea Biotec Ltd Human Vaccines Administered Orally Business Overview
7.13.3 Panacea Biotec Ltd Human Vaccines Administered Orally Major Product Offerings
7.13.4 Panacea Biotec Ltd Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.13.5 Panacea Biotec Ltd Key News
7.14 Bio-Med
7.14.1 Bio-Med Corporate Summary
7.14.2 Bio-Med Business Overview
7.14.3 Bio-Med Human Vaccines Administered Orally Major Product Offerings
7.14.4 Bio-Med Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.14.5 Bio-Med Key News
7.15 Halfkin Bio-Pharmaceuticals
7.15.1 Halfkin Bio-Pharmaceuticals Corporate Summary
7.15.2 Halfkin Bio-Pharmaceuticals Business Overview
7.15.3 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Major Product Offerings
7.15.4 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Sales and Revenue in Global (2017-2022)
7.15.5 Halfkin Bio-Pharmaceuticals Key News
8 GLOBAL HUMAN VACCINES ADMINISTERED ORALLY PRODUCTION CAPACITY, ANALYSIS
8.1 Global Human Vaccines Administered Orally Production Capacity, 2017-2028
8.2 Human Vaccines Administered Orally Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Vaccines Administered Orally Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 HUMAN VACCINES ADMINISTERED ORALLY SUPPLY CHAIN ANALYSIS
10.1 Human Vaccines Administered Orally Industry Value Chain
10.2 Human Vaccines Administered Orally Upstream Market
10.3 Human Vaccines Administered Orally Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Vaccines Administered Orally Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Human Vaccines Administered Orally in Global Market
Table 2. Top Human Vaccines Administered Orally Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Human Vaccines Administered Orally Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Human Vaccines Administered Orally Revenue Share by Companies, 2017-2022
Table 5. Global Human Vaccines Administered Orally Sales by Companies, (K Units), 2017-2022
Table 6. Global Human Vaccines Administered Orally Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Human Vaccines Administered Orally Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Human Vaccines Administered Orally Product Type
Table 9. List of Global Tier 1 Human Vaccines Administered Orally Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Vaccines Administered Orally Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Human Vaccines Administered Orally Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Human Vaccines Administered Orally Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Human Vaccines Administered Orally Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Human Vaccines Administered Orally Sales (K Units), 2017-2022
Table 15. By Type - Global Human Vaccines Administered Orally Sales (K Units), 2023-2028
Table 16. By Application – Global Human Vaccines Administered Orally Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Human Vaccines Administered Orally Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Human Vaccines Administered Orally Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Human Vaccines Administered Orally Sales (K Units), 2017-2022
Table 20. By Application - Global Human Vaccines Administered Orally Sales (K Units), 2023-2028
Table 21. By Region – Global Human Vaccines Administered Orally Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Human Vaccines Administered Orally Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Human Vaccines Administered Orally Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Human Vaccines Administered Orally Sales (K Units), 2017-2022
Table 25. By Region - Global Human Vaccines Administered Orally Sales (K Units), 2023-2028
Table 26. By Country - North America Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Human Vaccines Administered Orally Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Human Vaccines Administered Orally Sales, (K Units), 2017-2022
Table 29. By Country - North America Human Vaccines Administered Orally Sales, (K Units), 2023-2028
Table 30. By Country - Europe Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Human Vaccines Administered Orally Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Human Vaccines Administered Orally Sales, (K Units), 2017-2022
Table 33. By Country - Europe Human Vaccines Administered Orally Sales, (K Units), 2023-2028
Table 34. By Region - Asia Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Human Vaccines Administered Orally Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Human Vaccines Administered Orally Sales, (K Units), 2017-2022
Table 37. By Region - Asia Human Vaccines Administered Orally Sales, (K Units), 2023-2028
Table 38. By Country - South America Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Human Vaccines Administered Orally Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Human Vaccines Administered Orally Sales, (K Units), 2017-2022
Table 41. By Country - South America Human Vaccines Administered Orally Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Human Vaccines Administered Orally Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Human Vaccines Administered Orally Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Human Vaccines Administered Orally Sales, (K Units), 2023-2028
Table 46. Merck Corporate Summary
Table 47. Merck Human Vaccines Administered Orally Product Offerings
Table 48. Merck Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. GSK Corporate Summary
Table 50. GSK Human Vaccines Administered Orally Product Offerings
Table 51. GSK Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Sanofi Corporate Summary
Table 53. Sanofi Human Vaccines Administered Orally Product Offerings
Table 54. Sanofi Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Lanzhou Institute Corporate Summary
Table 56. Lanzhou Institute Human Vaccines Administered Orally Product Offerings
Table 57. Lanzhou Institute Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Serum Institute Corporate Summary
Table 59. Serum Institute Human Vaccines Administered Orally Product Offerings
Table 60. Serum Institute Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Valneva Corporate Summary
Table 62. Valneva Human Vaccines Administered Orally Product Offerings
Table 63. Valneva Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Shanghai United Cell Corporate Summary
Table 65. Shanghai United Cell Human Vaccines Administered Orally Product Offerings
Table 66. Shanghai United Cell Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Bibcol Corporate Summary
Table 68. Bibcol Human Vaccines Administered Orally Product Offerings
Table 69. Bibcol Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. PaxVax Corporate Summary
Table 71. PaxVax Human Vaccines Administered Orally Product Offerings
Table 72. PaxVax Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Vabiotech Corporate Summary
Table 74. Vabiotech Human Vaccines Administered Orally Product Offerings
Table 75. Vabiotech Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Tiantan Biological Corporate Summary
Table 77. Tiantan Biological Human Vaccines Administered Orally Product Offerings
Table 78. Tiantan Biological Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. EuBiologics Corporate Summary
Table 80. EuBiologics Human Vaccines Administered Orally Product Offerings
Table 81. EuBiologics Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Panacea Biotec Ltd Corporate Summary
Table 83. Panacea Biotec Ltd Human Vaccines Administered Orally Product Offerings
Table 84. Panacea Biotec Ltd Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Bio-Med Corporate Summary
Table 86. Bio-Med Human Vaccines Administered Orally Product Offerings
Table 87. Bio-Med Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Halfkin Bio-Pharmaceuticals Corporate Summary
Table 89. Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Product Offerings
Table 90. Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Human Vaccines Administered Orally Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 92. Global Human Vaccines Administered Orally Capacity Market Share of Key Manufacturers, 2020-2022
Table 93. Global Human Vaccines Administered Orally Production by Region, 2017-2022 (K Units)
Table 94. Global Human Vaccines Administered Orally Production by Region, 2023-2028 (K Units)
Table 95. Human Vaccines Administered Orally Market Opportunities & Trends in Global Market
Table 96. Human Vaccines Administered Orally Market Drivers in Global Market
Table 97. Human Vaccines Administered Orally Market Restraints in Global Market
Table 98. Human Vaccines Administered Orally Raw Materials
Table 99. Human Vaccines Administered Orally Raw Materials Suppliers in Global Market
Table 100. Typical Human Vaccines Administered Orally Downstream
Table 101. Human Vaccines Administered Orally Downstream Clients in Global Market
Table 102. Human Vaccines Administered Orally Distributors and Sales Agents in Global Market
Table 1. Key Players of Human Vaccines Administered Orally in Global Market
Table 2. Top Human Vaccines Administered Orally Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Human Vaccines Administered Orally Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Human Vaccines Administered Orally Revenue Share by Companies, 2017-2022
Table 5. Global Human Vaccines Administered Orally Sales by Companies, (K Units), 2017-2022
Table 6. Global Human Vaccines Administered Orally Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Human Vaccines Administered Orally Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Human Vaccines Administered Orally Product Type
Table 9. List of Global Tier 1 Human Vaccines Administered Orally Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Vaccines Administered Orally Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Human Vaccines Administered Orally Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Human Vaccines Administered Orally Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Human Vaccines Administered Orally Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Human Vaccines Administered Orally Sales (K Units), 2017-2022
Table 15. By Type - Global Human Vaccines Administered Orally Sales (K Units), 2023-2028
Table 16. By Application – Global Human Vaccines Administered Orally Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Human Vaccines Administered Orally Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Human Vaccines Administered Orally Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Human Vaccines Administered Orally Sales (K Units), 2017-2022
Table 20. By Application - Global Human Vaccines Administered Orally Sales (K Units), 2023-2028
Table 21. By Region – Global Human Vaccines Administered Orally Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Human Vaccines Administered Orally Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Human Vaccines Administered Orally Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Human Vaccines Administered Orally Sales (K Units), 2017-2022
Table 25. By Region - Global Human Vaccines Administered Orally Sales (K Units), 2023-2028
Table 26. By Country - North America Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Human Vaccines Administered Orally Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Human Vaccines Administered Orally Sales, (K Units), 2017-2022
Table 29. By Country - North America Human Vaccines Administered Orally Sales, (K Units), 2023-2028
Table 30. By Country - Europe Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Human Vaccines Administered Orally Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Human Vaccines Administered Orally Sales, (K Units), 2017-2022
Table 33. By Country - Europe Human Vaccines Administered Orally Sales, (K Units), 2023-2028
Table 34. By Region - Asia Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Human Vaccines Administered Orally Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Human Vaccines Administered Orally Sales, (K Units), 2017-2022
Table 37. By Region - Asia Human Vaccines Administered Orally Sales, (K Units), 2023-2028
Table 38. By Country - South America Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Human Vaccines Administered Orally Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Human Vaccines Administered Orally Sales, (K Units), 2017-2022
Table 41. By Country - South America Human Vaccines Administered Orally Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Human Vaccines Administered Orally Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Human Vaccines Administered Orally Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Human Vaccines Administered Orally Sales, (K Units), 2023-2028
Table 46. Merck Corporate Summary
Table 47. Merck Human Vaccines Administered Orally Product Offerings
Table 48. Merck Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. GSK Corporate Summary
Table 50. GSK Human Vaccines Administered Orally Product Offerings
Table 51. GSK Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Sanofi Corporate Summary
Table 53. Sanofi Human Vaccines Administered Orally Product Offerings
Table 54. Sanofi Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Lanzhou Institute Corporate Summary
Table 56. Lanzhou Institute Human Vaccines Administered Orally Product Offerings
Table 57. Lanzhou Institute Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Serum Institute Corporate Summary
Table 59. Serum Institute Human Vaccines Administered Orally Product Offerings
Table 60. Serum Institute Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Valneva Corporate Summary
Table 62. Valneva Human Vaccines Administered Orally Product Offerings
Table 63. Valneva Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Shanghai United Cell Corporate Summary
Table 65. Shanghai United Cell Human Vaccines Administered Orally Product Offerings
Table 66. Shanghai United Cell Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Bibcol Corporate Summary
Table 68. Bibcol Human Vaccines Administered Orally Product Offerings
Table 69. Bibcol Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. PaxVax Corporate Summary
Table 71. PaxVax Human Vaccines Administered Orally Product Offerings
Table 72. PaxVax Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Vabiotech Corporate Summary
Table 74. Vabiotech Human Vaccines Administered Orally Product Offerings
Table 75. Vabiotech Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Tiantan Biological Corporate Summary
Table 77. Tiantan Biological Human Vaccines Administered Orally Product Offerings
Table 78. Tiantan Biological Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. EuBiologics Corporate Summary
Table 80. EuBiologics Human Vaccines Administered Orally Product Offerings
Table 81. EuBiologics Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Panacea Biotec Ltd Corporate Summary
Table 83. Panacea Biotec Ltd Human Vaccines Administered Orally Product Offerings
Table 84. Panacea Biotec Ltd Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Bio-Med Corporate Summary
Table 86. Bio-Med Human Vaccines Administered Orally Product Offerings
Table 87. Bio-Med Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Halfkin Bio-Pharmaceuticals Corporate Summary
Table 89. Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Product Offerings
Table 90. Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. Human Vaccines Administered Orally Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 92. Global Human Vaccines Administered Orally Capacity Market Share of Key Manufacturers, 2020-2022
Table 93. Global Human Vaccines Administered Orally Production by Region, 2017-2022 (K Units)
Table 94. Global Human Vaccines Administered Orally Production by Region, 2023-2028 (K Units)
Table 95. Human Vaccines Administered Orally Market Opportunities & Trends in Global Market
Table 96. Human Vaccines Administered Orally Market Drivers in Global Market
Table 97. Human Vaccines Administered Orally Market Restraints in Global Market
Table 98. Human Vaccines Administered Orally Raw Materials
Table 99. Human Vaccines Administered Orally Raw Materials Suppliers in Global Market
Table 100. Typical Human Vaccines Administered Orally Downstream
Table 101. Human Vaccines Administered Orally Downstream Clients in Global Market
Table 102. Human Vaccines Administered Orally Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Human Vaccines Administered Orally Segment by Type
Figure 2. Human Vaccines Administered Orally Segment by Application
Figure 3. Global Human Vaccines Administered Orally Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Human Vaccines Administered Orally Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Human Vaccines Administered Orally Revenue, 2017-2028 (US$, Mn)
Figure 7. Human Vaccines Administered Orally Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Human Vaccines Administered Orally Revenue in 2021
Figure 9. By Type - Global Human Vaccines Administered Orally Sales Market Share, 2017-2028
Figure 10. By Type - Global Human Vaccines Administered Orally Revenue Market Share, 2017-2028
Figure 11. By Type - Global Human Vaccines Administered Orally Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Human Vaccines Administered Orally Sales Market Share, 2017-2028
Figure 13. By Application - Global Human Vaccines Administered Orally Revenue Market Share, 2017-2028
Figure 14. By Application - Global Human Vaccines Administered Orally Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Human Vaccines Administered Orally Sales Market Share, 2017-2028
Figure 16. By Region - Global Human Vaccines Administered Orally Revenue Market Share, 2017-2028
Figure 17. By Country - North America Human Vaccines Administered Orally Revenue Market Share, 2017-2028
Figure 18. By Country - North America Human Vaccines Administered Orally Sales Market Share, 2017-2028
Figure 19. US Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Human Vaccines Administered Orally Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Human Vaccines Administered Orally Sales Market Share, 2017-2028
Figure 24. Germany Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 25. France Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Human Vaccines Administered Orally Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Human Vaccines Administered Orally Sales Market Share, 2017-2028
Figure 33. China Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 37. India Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Human Vaccines Administered Orally Revenue Market Share, 2017-2028
Figure 39. By Country - South America Human Vaccines Administered Orally Sales Market Share, 2017-2028
Figure 40. Brazil Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Human Vaccines Administered Orally Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Human Vaccines Administered Orally Sales Market Share, 2017-2028
Figure 44. Turkey Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 48. Global Human Vaccines Administered Orally Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Human Vaccines Administered Orally by Region, 2021 VS 2028
Figure 50. Human Vaccines Administered Orally Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Human Vaccines Administered Orally Segment by Type
Figure 2. Human Vaccines Administered Orally Segment by Application
Figure 3. Global Human Vaccines Administered Orally Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Human Vaccines Administered Orally Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Human Vaccines Administered Orally Revenue, 2017-2028 (US$, Mn)
Figure 7. Human Vaccines Administered Orally Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Human Vaccines Administered Orally Revenue in 2021
Figure 9. By Type - Global Human Vaccines Administered Orally Sales Market Share, 2017-2028
Figure 10. By Type - Global Human Vaccines Administered Orally Revenue Market Share, 2017-2028
Figure 11. By Type - Global Human Vaccines Administered Orally Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Human Vaccines Administered Orally Sales Market Share, 2017-2028
Figure 13. By Application - Global Human Vaccines Administered Orally Revenue Market Share, 2017-2028
Figure 14. By Application - Global Human Vaccines Administered Orally Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Human Vaccines Administered Orally Sales Market Share, 2017-2028
Figure 16. By Region - Global Human Vaccines Administered Orally Revenue Market Share, 2017-2028
Figure 17. By Country - North America Human Vaccines Administered Orally Revenue Market Share, 2017-2028
Figure 18. By Country - North America Human Vaccines Administered Orally Sales Market Share, 2017-2028
Figure 19. US Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Human Vaccines Administered Orally Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Human Vaccines Administered Orally Sales Market Share, 2017-2028
Figure 24. Germany Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 25. France Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Human Vaccines Administered Orally Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Human Vaccines Administered Orally Sales Market Share, 2017-2028
Figure 33. China Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 37. India Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Human Vaccines Administered Orally Revenue Market Share, 2017-2028
Figure 39. By Country - South America Human Vaccines Administered Orally Sales Market Share, 2017-2028
Figure 40. Brazil Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Human Vaccines Administered Orally Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Human Vaccines Administered Orally Sales Market Share, 2017-2028
Figure 44. Turkey Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Human Vaccines Administered Orally Revenue, (US$, Mn), 2017-2028
Figure 48. Global Human Vaccines Administered Orally Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Human Vaccines Administered Orally by Region, 2021 VS 2028
Figure 50. Human Vaccines Administered Orally Industry Value Chain
Figure 51. Marketing Channels
